SEC Form 4 · accession 0001645627-17-000049
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 27, 2017
Accepted (ET)
May 2, 2017 · 10:56 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 27, 2017 | P | 1,000 | $0.0848 | A | 20,480,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.092 | A | 20,481,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.095 | A | 20,482,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.0995 | A | 20,483,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.099 | A | 20,484,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.099 | A | 20,485,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.099 | A | 20,486,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.099 | A | 20,487,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.097 | A | 20,488,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.097 | A | 20,489,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.096 | A | 20,490,449 | D | |
| Common Stock | Apr 28, 2017 | P | 700 | $0.096 | A | 20,491,149 | D | |
| Common Stock | Apr 28, 2017 | P | 300 | $0.0969 | A | 20,491,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.097 | A | 20,492,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.096 | A | 20,493,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.099 | A | 20,494,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.099 | A | 20,495,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.0898 | A | 20,496,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.085 | A | 20,497,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.0897 | A | 20,498,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.0899 | A | 20,499,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.0898 | A | 20,500,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.0899 | A | 20,501,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.0898 | A | 20,502,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.0863 | A | 20,503,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.0863 | A | 20,504,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.0862 | A | 20,505,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.0859 | A | 20,506,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.0856 | A | 20,507,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.0859 | A | 20,508,449 | D |
Table II — derivative securities
No Table II lines on this filing.